Intuitive Surgical (ISRG) Stock
Robotic surgery leader selling instruments and service contracts. Here's the price, business snapshot, and what's worth knowing about Intuitive Surgical in October 2026.
Intuitive Surgical (ISRG) is the dominant name in robotic-assisted surgery, best known for its da Vinci surgical systems that enable minimally invasive procedures. With a sizeable installed base and recurring revenue from instruments, accessories and service contracts, the company has built a high-margin business that benefits as hospitals upgrade systems and expand robotic programmes. Key growth drivers include wider clinical adoption across specialties, new product introductions and expansion into less invasive procedures. Investors should weigh these opportunities against concentration risks — substantial reliance on a single product family, ongoing R&D spending, regulatory and reimbursement dynamics, and sensitivity to hospital capital budgets. Competition from established medical groups and new robotics entrants is rising. The market cap (~$165.9bn) reflects premium expectations of persistent growth and margin expansion; such expectations can reverse. This overview is educational and not investment advice — consider your risk tolerance and seek personalised guidance before acting.
Why It’s Moving
ISRG Shares Rally on Strong Q3 Beat and Upgraded Analyst Forecasts Despite Margin Headwinds
- Q3 results exceeded expectations with non-GAAP EPS of $3 (vs. $2.61 estimate) and 22% revenue growth to over $3 billion, fueled by rising procedure volumes and solid system sales.
- Management highlighted a strategic pivot to lower instrument prices in high-volume benign procedures to expand the addressable market, aiming for long-term adoption despite near-term margin impacts.
- Following the earnings release, ISRG was added to Zacks' 'Strong Buy' list and crossed above its 200-day moving average, signaling renewed technical and fundamental investor confidence.
ISRG Shares Rally on Strong Q3 Beat and Upgraded Analyst Forecasts Despite Margin Headwinds
- Q3 results exceeded expectations with non-GAAP EPS of $3 (vs. $2.61 estimate) and 22% revenue growth to over $3 billion, fueled by rising procedure volumes and solid system sales.
- Management highlighted a strategic pivot to lower instrument prices in high-volume benign procedures to expand the addressable market, aiming for long-term adoption despite near-term margin impacts.
- Following the earnings release, ISRG was added to Zacks' 'Strong Buy' list and crossed above its 200-day moving average, signaling renewed technical and fundamental investor confidence.
Sixth Month Growth Performance
When is the next earnings date for INTUITIVE SURGICAL INC (ISRG)?
Intuitive Surgical has not yet confirmed a specific date for its next earnings release. Based on the company's historical reporting pattern, which typically follows a quarterly cycle of approximately three months, the upcoming report is expected in late January 2027. This anticipated filing will cover financial results for the fourth quarter of fiscal year 2026. Investors should monitor official announcements for the precise scheduling of this event.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Intuitive Surgical's stock, predicting it could rise significantly in value.
Financial Health
Intuitive Surgical is performing well with strong revenue and profit margins, indicating solid financial stability.
Dividend
Intuitive Surgical does not pay a dividend, which may indicate it reinvests profits for growth. If you invested $1000, you would receive $0 a year in dividends.
Baskets Featuring ISRG
Global Medtech UAE Healthcare Investment Basket 2025
The United Arab Emirates is making significant investments to upgrade its medical infrastructure, aiming to become a global healthcare destination. This basket provides exposure to the international US and EU-listed companies in pharmaceuticals, medtech, and digital health that supply this ambitious national project.
Published: 12 November 2025
Explore BasketHealthcare Innovation Brazil Investment Theme 2025
Brazil is ramping up investment to enhance its healthcare quality and access, creating significant opportunities for innovation. This basket offers exposure to key US and EU-listed companies providing the medical devices, software, and biotech research driving this transformation.
Published: 30 October 2025
Explore BasketMedTech Stocks: Brazil Market Risks & Opportunities
Brazil's growing demand for advanced healthcare presents an opportunity to modernize its medical infrastructure and improve patient outcomes. This basket offers exposure to the leading US and European companies supplying Brazil with robotic surgery systems, AI diagnostics, and innovative medical devices.
Published: 21 October 2025
Explore BasketNiche Dominators
These carefully selected companies rule their specialized markets by design. They've built powerful competitive advantages in focused segments that larger companies often overlook, creating a path to consistent profits and sustainable growth.
Published: 17 June 2025
Explore BasketPatient Platforms
This carefully curated collection features companies building the technological foundations that will power innovation for decades to come. Our analysts have identified businesses creating essential infrastructure in genomics, AI, robotics, and advanced computing—platforms that could define their industries and generate substantial long-term returns.
Published: 17 June 2025
Explore BasketAI & Robotics Architects
Invest in companies that own the foundational patents powering our AI future. These carefully selected stocks represent firms whose intellectual property forms the blueprint for machine learning and automation, giving them a powerful competitive advantage for years to come.
Published: 17 June 2025
Explore BasketRestless Innovators
Companies that refuse to stand still, constantly pushing boundaries and redefining what's possible. These stocks have been carefully selected by our analysts for their relentless pursuit of innovation and potential for long-term growth.
Published: 17 June 2025
Explore BasketFuture Tech: World Changing Ideas
Get ahead of tomorrow's innovations with this collection of stocks pushing technological boundaries. Our analysts have carefully selected companies developing flying cars, breakthrough medical treatments, and robotic surgery that could reshape our future.
Published: 25 May 2025
Explore BasketWhy You’ll Want to Watch This Stock
Recurring revenue model
Consumables and service contracts create predictable follow-on sales, though hospital budgets and procedure volumes can affect revenue.
Innovation and R&D
Regular product updates and new platforms can open markets, but they require heavy R&D and face regulatory hurdles.
Global adoption trends
Growing use of minimally invasive surgery offers a large addressable market, yet adoption and reimbursement vary by region.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
